M28 Capital Management

Latest statistics and disclosures from M28 Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are WVE, IVVD, RCKT, SLN, CRIS, and represent 83.72% of M28 Capital Management's stock portfolio.
  • Added to shares of these 1 stock: WVE.
  • Reduced shares in these 2 stocks: SWTX, Neximmune.
  • Sold out of its position in Neximmune.
  • M28 Capital Management was a net seller of stock by $-371k.
  • M28 Capital Management has $121M in assets under management (AUM), dropping by 38.42%.
  • Central Index Key (CIK): 0001807489

Tip: Access up to 7 years of quarterly data

Positions held by M28 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for M28 Capital Management

M28 Capital Management holds 10 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Wave Life Sciences SHS (WVE) 30.8 $37M +4% 7.4M 5.05
 View chart
Adagio Therapeutics (IVVD) 30.2 $36M 9.2M 3.94
 View chart
Rocket Pharmaceuticals (RCKT) 13.0 $16M 523k 29.97
 View chart
Silence Therapeutics Ads (SLN) 5.2 $6.3M 364k 17.37
 View chart
Curis (CRIS) 4.5 $5.4M 422k 12.75
 View chart
Springworks Therapeutics (SWTX) 4.3 $5.2M -27% 143k 36.50
 View chart
Bridgebio Pharma (BBIO) 4.1 $4.9M 121k 40.37
 View chart
Proqr Thrapeutics N V Shs Euro (PRQR) 3.1 $3.8M 1.9M 1.98
 View chart
Tg Therapeutics (TGTX) 3.1 $3.7M 217k 17.08
 View chart
Arrowhead Pharmaceuticals (ARWR) 1.7 $2.1M 67k 30.60
 View chart

Past Filings by M28 Capital Management

SEC 13F filings are viewable for M28 Capital Management going back to 2021